Hong Kong pharma start-up joins with Singapore technology agency in venture fund

Aptorum Group, a Hong Kong drug developer listed on Nasdaq, will invest in health care start-ups in Singapore, working alongside the city state’s government technology agency to channel US$90 million …
( read original story …)

---